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PURPOSE: To test the possibility of obtaining a practical and stable model of hyperinsulinemia and hyperglycemia in hamsters,
substituting the drinking water by 10% or 20% fructose solutions for a period of 2, 4, or 6 months.
METHODS: Male hamsters were divided into 3 main groups, further divided in 3 subgroups: Two months: Group Ia control (n =
51) received filtered water, Group Ib (n = 49) received 10% fructose solution instead of water, Group Ic (n=8) received 20%
fructose solution instead of water. Four months: Group IIa control (n=8), Group IIb 10% fructose (n = 7), Group IIc 20% fructose
(FIIc, n = 7). Six months: Group IIIa control (n = 6), Group IIIb 10% Fructose (n = 6), Group IIIc 20% Fructose (n = 5). All groups
were fed with the same laboratory diet. The animals were weighed every 2 weeks during the study period. On the final day of each
experiment (61st, 121st, and 181st day after the beginning of the study, respectively), the animals were weighed and anesthetized
for blood collection to determine plasma glucose and insulin after at least a 12-h fast. Ten animals of group Ia and 10 of group Ib
were evaluated to determine changes in macromolecular permeability induced by ischemia/reperfusion as measured in the cheek
pouch microcirculation.
RESULTS: Compared to controls, the animals that drank the 10% or 20% fructose solution had significantly greater weight gain
(P < .001), fasting plasma glucose (P < .001) Reperfusion, after 30 min ischemia, resulted in an immediate but reversible increase
in postcapillary leakage (L) of 89.0 ± 2.0 L/cm2 (group Ia - controls), and 116.5 ± 4.8 L/cm2 (group Ib 10% fructose), P <
.001.These results suggest that chronic administration of either 10% or 20% fructose solutions could be used to experimentally
induce a stable hamster model of hyperinsulinemia and hyperglycemia.
CONCLUSION: The model might facilitate the study of basic mechanisms of hyperglycemia and hyperinsulinemia affecting the
microvasculature as demonstrated by the findings regarding ischemia/reperfusion after only 2 months of treatment.
KEYWORDS: Insulinemia. Hyperglycemia. Fructose solution. Experimental animal model. Hamster.
INTRODUCTION
Diabetes mellitus comprises a group of metabolic dis-
eases characterized by hyperglycemia resulting from de-
fects in insulin secretion, insulin action, or both; long-
term it is associated with permanent damage, dysfunc-
tion, and failure of various organs.1 Several pathogenic
processes are involved in the development of diabetes,
ranging from autoimmune destruction of pancreatic b-
cells (type 1) with consequent insulin defficiency to ab-
normalities that result in insulin resistance. Type 2 dia-
betes, which accounts for 90% to 95% of those with dia-
betes, is among the most common of chronic diseases
and comprises individuals who have insulin resistance
and usually relative (rather than absolute) insulin defi-
ciency. Glucose intolerance and hyperglycemia super-
vene only when the pancreatic ß-cell is unable to main-
tain compensatory hyperinsulinemia to overcome tissue
resistance to insulin action.2
It has been estimated that the number of persons af-
fected with type 2 diabetes worldwide will increase from
135 million to over 300 million by 2025, with most of
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this increase occurring in developing countries.3 This dis-
ease is frequently associated with other metabolic ab-
normalities, sometimes called the “metabolic syndrome”
or syndrome X, which includes central obesity, hyper-
lipidemia, hypertension, and accelerated atherosclerosis;
other abnormalities such as sleep apnea may also be as-
sociated 4–7 This cluster of abnormalities is associated
with a higher incidence of cardiovascular morbidity and
mortality.8 The difficulty in avoiding these complications
is well known in clinical practice, but an adequate con-
trol of glycemia through medical monitoring, adherence
to treatment, and awareness of the patient with respect
to the disease could delay their appearance.9
Experimental models could be very useful in the study
of these complications. A good and well used experimen-
tal model consists of an intraperitoneal injection of
streptozotocin or alloxan, which destroys the pancreas ß-
cells, the only cells in the body that make a meaningful
quantity of insulin10-12 and consequently produces mod-
els of hyperglycemia and hypoinsulinemia. However, the
fastest growing type of diabetes mellitus, type 2 diabe-
tes, characterized by hyperglycemia and hyperinsulinemia,
has few well characterized experimental models; as a rule,
it is not easily produced in the laboratory. Insulin resist-
ance has been reported in several animal models, includ-
ing spontaneously hypertensive rats, Zucker fatty rats, in-
sulin receptor substrate-1 (IRS-1)-knockout mice, and
fructose-fed rats.13-15
The major predisposing factors to type 2 diabetes are
obesity, decreased activity, and increasing age.16 Epide-
miological studies in several countries have shown the
influence of the diet composition on insulin action and
on plasma glucose levels. Among these studies, it is re-
ported that fructose ingestion causes insulin resistance,
hyperglycemia, and hypertriglyceridemia in rats.17,18
Fructose-fed Sprague Dawley rats fed with 60% fructose-
rich chow (i) for 4 weeks showed a reduction in the up-
take of tritiated glucose by adypocytes in vitro and in
endothelium-dependent vasodilation induced by acetyl-
choline in aortic strips,19 (ii) for 6 weeks showed a re-
duction to 80% in tyrosine phosphorilation of IRS-1 in
the soleus muscle,20 and (iii) for 40 weeks showed a sig-
nificant increase in fasting plasma insulin without
hyperglycemia, a decrease of muscarinic receptors, an
increased dependence on nitric oxide (NO), and an im-
pairment of α2-adrenergic-mediated relaxation.21 Substi-
tution of drinking water by 10% fructose solution in-
duced a small increase in glycemia without significant
changes in body weight, glycosilated hemoglobin,
insulinemia, or triglyceridemia.22 Based on these reports,
fructose was elected for testing. The objective was to test
the possibility of obtaining a practical and stable model
of hyperinsulinemia and hyperglycemia in small rodents,
such as hamsters, where further studies of the microcir-
culation (cheek pouch, cremaster, dorsal chamber, etc.)
could be performed. The continuous substitution of the
drinking water by a fructose solution seemed easier than
adding this carbohydrate to the animal chow. Two con-
centrations of fructose were tested, 10% and 20%, and
the stability of the model was determined by measuring
fasting plasma glucose and insulin in these animals at
2, 4, and 6 months after the substitution.  The use of
this model was tested 2 months after the substitution by
measuring changes in macromolecular permeability in-
duced by ischemia/reperfusion in the cheek pouch mi-
crocirculation.
MATERIALS AND METHODS
One hundred and forty-seven male Syrian golden
hamsters (Mesocricetus auratus), 7 to 10 weeks old,
weighing approximately 100 g, obtained from ANILAB,
Paulínia, SP, Brazil, were used. Upon arrival, the ani-
mals were maintained in the animal house of the Labo-
ratory for Research in Microcirculation, with tempera-
ture controlled at 21.0° ± 1.0°C and daylight/dark peri-
ods of 12/12 h for 2 weeks. During this period, they re-
ceived appropriate animal diet for small rodents, Nuvital
from Nuvilab, Curitiba, PR, Brazil and filtered water ad
libitum. This laboratory diet followed the criteria rec-
ommended by AIN-9323 and was maintained for all ani-
mals during the entire experimental period. After these
2 weeks in the animal house, the hamsters were weighed
and divided into 3 main groups: 2 months (Group I), 4
months (Group II), and 6 months (Group III). Each group
was further divided into 3 subgroups as follows. Group
Ia control (n = 51) continued unchanged, ie, continued
to drink filtered water; For Group Ib (n = 49) drinking
water was replaced by a 10% fructose solution; for
Group Ic (n = 8) drinking water by a 20% fructose so-
lution. These 3 groups were followed for 60 days. In the
second subdivision of groups, Group IIa control (n = 8)
continued unchanged, ie, continued to drink filtered wa-
ter; Group IIb (n = 7) had the substitution of drinking
water by a 10% fructose solution; and Group IIc (n = 7)
had the substitution of drinking water by a 20% fruc-
tose solution. These 3 groups were followed for 120
days. In the third subdivision, Group IIIa control (n =
6) continued unchanged, ie, continued to drink filtered
water; Group IIIb (n = 6) had the substitution of drink-
ing water by a 10% fructose solution; and Group IIIC
(n = 5) had the substitution of the drinking water by a
329
CLINICS 2007;62(3):327-34 Substitution of drinking water by fructose solution
Barros CMMR et al.
20% fructose solution. These 3 groups were followed for
180 days. All the animals were weighed every 2 weeks
to evaluate the gain in body mass in all groups.
The following experiments were performed on the fi-
nal day of this project: (61st, 121st, and 181st day, re-
spectively), according to protocols approved by the Ethi-
cal Committee of the State University of Rio de Janeiro
(H36/94), always after a 12-h fast. The animals were
anesthetized with an intraperitoneal injection, 0.2 mL/
100 g body weight, of sodium pentobarbital (Pentobar-
bital sodique, Sanofi, France, 60 mg/mL), and their body
temperature was maintained at 37.5° ± 0.5°C with a
heating pad controlled by a rectal thermistor (LB750
Thermostat System, Upsala Processdata AB, Sweden).
Plasma glucose was evaluated through periorbital punc-
ture using a One Touch® brand basic glucose meter and
One Touch test strips (Lifescan Inc, Johnson & Johnson
Co., Milpitas, CA, U.S.A.), always after at least a 12-h
fast. Soon after the described process, 20 animals were
exsanguinated through cardiac puncture using a syringe
and needle. Approximately 2.5 mL of blood was col-
lected from each animal. Each sample was centrifuged,
and the serum was stored in a freezer for subsequent bio-
chemical analysis of insulin assayed by radioimmu-
noassay using an 125I insulin kit (BioTrak, Amersham-
Pharmacia Biotech, Piscataway, NJ, USA).21 In 20 ani-
mals, 10 from Group CIa and 10 from Group FIb, cheek
pouches of anesthetized animals were prepared for in-
travital microscopy. Local ischemia was obtained by
clampling the neck of the everted pouch and the increase
in microvascular permeability was quantified as leakage
of intravenously injected fluorescein isothiocyanate-la-
belled dextran (FITC-dextran 150; MW = 150000).
In statistical presentations, estimates are given as
means ± standard error of the mean (SEM), unless other-
wise noted. Significance tests were done with analysis of
variance (ANOVA). Statistical significance was declared
when P < .05.
RESULTS
 All the subgroups in the 3 groups evolved with pro-
gressively increasing body weights throughout the experi-
mental period, but the fructose groups (Ib, Ic, IIb, IIc, IIIb,
and IIIc) had significantly higher (P < .001) increases (Ta-
bles 1-3).
Fasting plasma glucose concentrations (mg/dL) were
significantly higher in the groups of animals drinking
Table 3 - Variation of body weight (g) in animals treated for 6 months with filtered water, 10%, or 20% fructose solution
and the standard laboratory diet. Results are expressed as mean ± SEM.
Treatment Time (months)
0 1 2 3 4 5 6 PANOVA
Filt. water (n=6) 101,4g ± 1,24 6,8% ± 1,19 16,8% ± 1,19 19,7% ± 1,19 23,0% ± 1,19 25,1% ± 1,19 28,5% ± 1,19 0,0001*
F10% Sol. (n=6) 97,5g ± 1,16 13,2% ± 1,19 28,4% ± 1,19 33,5% ± 1,19 39,2% ± 1,19 42,9% ± 1,19 44,7% ± 1,19
F20% Sol. (n=5) 97,6g ± 1,18 14,8% ± 1,19 31,5% ± 1,19 38,1% ± 1,19 43,8% ± 1,19 46,9% ± 1,19 47,6% ± 1,19
Table 2 - Variation of body weight (g) in animals treated for 4 months with filtered water, 10%, or 20% fructose solution
and the standard laboratory diet. Results are expressed as mean ± SEM.
Treatment Time (months)
0 1 2 3 4 PANOVA
Filtered water (n=8) 94,0g ± 1,31 8,3% ± 0,02 19,2% ± 0,03 22,8% ± 0,02 24,3% ± 0,02 0,0006*
Fructose 10% Solution (n=7) 97,2g ± 1,12 14,6% ± 0,01 30,3% ± 0,02 34,1% ± 0,02 41,5% ± 0,01
Fructose 20% Solution (n=7) 98,9g ± 1,19 16,2% ± 0,02 29,7% ± 0,02 37,4% ± 0,02 43,6% ± 0,03
Table 1 - Variation of body weight (g) in animals treated for 2 months with filtered water, 10%, or 20% fructose solution
and the standard laboratory diet. Results are expressed as mean ± SEM.
Treatment Time (days)
0 15 30 45 60 PANOVA
Filtered water (n=51) 98,6g ± 1,05 5,4% ± 0,01 10,5% ± 0,01 16,6% ± 0,01 18,7% ± 0,02 0,0009*
Fructose 10% Solution (n=49) 99,5g ± 1,00 10,7% ± 0,01 15,3% ± 0,02 20,3% ± 0,02 28,0% ± 0,02
Fructose 20% Solution (n=8) 97,6g ± 1,47 9,8% ± 0,03 15,6% ± 0,02 22,7% ± 0,03 31,0% ± 0,03
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10% or 20% fructose solutions compared to the ones
drinking filtered water during the 3 experimental peri-
ods, as follows: Ia, 93.6 ± 2.9; Fib,149.6 ± 5.2; Fic,
141.5 ± 7.1, P < .001 (Figure 1a); CIIa, 80.3 ± 5.2; FIIb,
137.5 ± 8.6; FIIc, 137.7 ± 8.8, P < .001 (Figure 2a); and
CIIIa, 88.4 ± 2.3; FIIIb, 136.0 ± 5.6; FIIIc, 137.7 ± 8.8,
P < .001 (Figure 3a). No difference was observed be-
tween 10 vs. 20% fructose treatment, in any of the three
main groups.
Similarly, fasting plasma insulin concentrations (µUI/
mL) were significantly higher in the groups of animals
drinking 10% or 20% fructose solutions compared to the
ones drinking filtered water during the 3 experimental
periods, as follows: CIa, 67.7 ± 8.4; FIb, 137.5 ± 9.9;
FI, 134.1 ± 8.9, P < .001 (Figure 1b); CIIa, 50.9 ± 9.3;
FIIb, 135.5 ± 8.0; FIIc, 137.0 ± 11.4, P < .001 (Figure
2b); and CIIIa, 78.7 ± 4.5; FIIIb, 125.0 ± 12.7; FIIIc,
126.6 ± 11.2, P < .001 (Figure 3b). Again, no difference
was observed between 10 vs. 20% fructose treatment, in
any of the three main groups.
Reperfusion, after 30 min ischemia, resulted in a signifi-
cant immediate, but reversible, increase in postcapillary leak-
age (L) in Group FI compared with Group CI of 116.5 ±
4.8 L/cm2 vs 89.0 ± 2.0 L/cm2, respectively (P < .001).
Figure 2 -  Effects on glycemia (a) and insulinemia (b) of filtered water, 10%
fructose solution, or 20% fructose solution on animals treated for 4 months.
Results expressed as mean ± SEM; *** = P < .001 compared to controls.
Figure 1 - Effects on glycemia (a) and insulinemia (b) of filtered water, 10%
fructose solution, or 20% fructose solution on animals treated for 2 months..
Results expressed as mean ± SEM; *** = P < .001 compared to controls.
Figure 3 - Effects on glycemia (a) and insulinemia (b) of filtered water, 10%
fructose solution, or 20% fructose solution on animals treated for 6 months..
Results expressed as mean ± SEM; *** = P < .001 compared to controls.
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Differential duration of the experimental period did
not cause significant changes in the studied parameters,
which strongly suggests that the model is stable.
DISCUSSION
The effect of chronic treatment with fructose on body
weight has been well established experimentally.24 Pre-
vious studies in our laboratory have demonstrated that
the substitution of drinking water by 10% fructose so-
lution increases weight gain when used continuously for
2, 4, and 6 months.25,26 Since fructose consumption in
the diet in the form of sacarose is increasing in indus-
trialized and developing countries, this is important in-
formation for the public health system.
The increase in body mass was greater in the groups
that drank 10% or 20% fructose solution (Ib, Ic, IIb, IIc,
IIIb, and IIIc) compared to those that drank filtered wa-
ter (Ia, IIa, and IIIa). This result may be explained by
an increase in total caloric intake by the fructose groups
during the experimental period. Fructose is an energy-
generating molecule that helps to build and maintain
body mass. The observed increase in plasma insulin lev-
els in these groups could also contribute to the weight
gain. Insulin, a hormone essential for life, exerts criti-
cal control over carbohydrate, fat, and protein metabo-
lism. Control animals (filtered water) did not show the
same weight gain because water is not an energy-gen-
erating molecule, and no increase in plasma insulin lev-
els was detected in these groups (Ia, IIa, and IIIa). How-
ever, using a similar model, namely substitution of drink-
ing water by 10% fructose solution for 18 weeks, Félétou
and co-workers22 found no significant increase in body
weight compared to control hamsters.
Glucose homeostasis in the fasting state is the bal-
ance between glucose production by the liver and glu-
cose utilization by muscle and fat. Although the fine-
tuning of glucose metabolism may be influenced by
many hormones and metabolic intermediates, normal
glucose disposal depends primarily on 4 factors: (1) the
ability of the body to secrete insulin acutely and in a
sustained fashion, (2) the ability of insulin to inhibit he-
patic glucose output, (3) the ability of glucose to pro-
mote glucose disposal or insulin sensitivity, and (4) the
ability of glucose to enter the cells in the absence of in-
sulin.27 The pathogenesis of type 2 diabetes appears to
involve at least 2 defects in this regulation system. The
earliest detectable lesion is insulin resistance in periph-
eral tissues16,28,29 progressing to hyperinsulinemia and
hyperglycemia.
In our studies, animals subjected to substitution of
drinking water by 10% fructose solution showed a sig-
nificant increase in glycemia, similar to findings reported
by Hwang and co-workers30,31 and Félétou and co-work-
ers.32 Addition of fructose to the diet of rats for a long
period also elicited an increase in plasma insulin lev-
els.33 In the present study, however, the extent of the
metabolic changes induced by fructose was markedly
more severe than that reported under similar experimen-
tal conditions22 where only glycemia was significantly
different from controls. In various animal models, in-
cluding hamsters, hyperinsulinemia, hypertriglyceride-
mia, hypercholesterolemia, and insulin resistance have
been reported with a fructose-enriched diet.34,35 In con-
trast, fasting glycemic levels were not affected in those
studies. These discrepancies with the present study could
be explained primarily by the severity of the diet. Most
studies are performed with food containing fructose that
was 60% of the total caloric intake,30 leading to a daily
intake of approximately 16 g of fructose/hamster33 in-
stead of the 1 to 2.4 g ingested in the present study.
There is no significant difference in the substitution of
drinking water by either a 10% or 20% fructose solu-
tion, probably because, even with the 20% fructose so-
lution, the ingestion of fructose is low.30,34 The present
study measured nonfasting plasma glucose and insulin
while other works reported fasting plasma glucose and
insulin.
Most of the metabolic effects of fructose are possi-
bly due to its rapid utilization by the liver and its by-
passing the phosphofructokinase regulatory step, with
clear consequencences to carbohydrate and lipid me-
tabolism, such as hepatic increase in pyruvate and lac-
tate production, activation of pyruvate dehydrogenase,
and a balance change from oxidation to esterification
of nonesterified fatty acids, resulting in increased se-
cretion of very-low-density-lipoprotein (VLDL).35 The
long-term consequence of fructose absorption leads to
triglyceridemia, decreased glucose tolerance, and
hyperinsulinemia.36
The finding that the hyperglycemia is accompanied
by hyperinsulinemia after a continuous use of 10% or
20% fructose solution for at least 2 months, similarly
to what is found in type II diabetic patients, suggests that
this could be a model for experimentally studying vas-
cular damages elicited by these changes as well as the
efficacy of possible treatments. The results obtained re-
garding the increase in macromolecular permeability in-
duced by ischemia/reperfusion show that this model is
useful for demonstrating the effects of increased plasma
glucose and insulin on the microcirculation even after
only 2 months of substitution of drinking water by a 10%
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fructose solution. One advantage of this model is its tem-
poral stability. Moreover, the substitution of the drink-
ing water by a 10% fructose solution is easier to accom-
plish than the addition of fructose to the laboratory diet
offered to the animal.
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RESUMO
Barros CMMR, Lessa RQ, Grechi MP, Mouço TLM, Souza
MGC, Wiernsperger N. Bouskela E. Substituição da água
por solução de frutose induz hiperinsulinemia e hiper-
glicemia em hamster. Clinics. 2007;62(3):327-34.
OBJETIVO: Testar a possibilidade de obtenção de um
modelo prático e estável de hiperinsulinemia e hiper-
glicemia em hamsters substituindo a água de beber por
soluções de frutose a 10% ou 20% por um período de dois,
quatro ou seis meses.
MÉTODOS: Hamsters machos foram divididos em 3
grupos e cada grupo subdividido em 3 subgrupos. Dois
meses: Grupo Ia–controle (n=51), recebeu água filtrada,
Grupo Ib–(n=49), recebeu solução de frutose a 10% ao
invés de água e Grupo Ic–( n=8), recebeu solução de frutose
a 20% ao invés de água. Quatro meses: Grupo IIa - controle
(n=8), Grupo IIb - 10% frutose (n=7) e Grupo IIc - 20%
frutose (n=7). Seis meses: Grupo IIIa - controle (n=6),
Grupo IIIb - 10% frutose (n=6) e Grupo IIIc - 20% frutose
(n=5). Todos os animais foram alimentados com a mesma
dieta padrão de laboratório. Os animais foram pesados a
cada 2 semanas durante o período do estudo. No dia do
final do experimento (61º, 121º e 181º dia, respectivamente,
após o início do estudo), os animais foram pesados e
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anestesiados para coleta de sangue para determinação da
glicose e da insulina sérica, após jejum de pelo menos 12 h.
Em 10 animais do grupo Ia e em 10 do grupo Ib avaliamos,
na microcirculação da bolsa da bochecha, a variação da
permeabilidade a macromoléculas induzida por isquemia/
reperfusão.
RESULTADOS: Comparados ao grupo controle, os
animais que beberam soluções de frutose a 10 ou 20%
tiveram um aumento significativo de massa corporal
(p<0,001) e da glicemia de jejum (p<0,001). Durante o
experimento de reperfusão, após 30 min de isquemia, houve
um aumento imediato e reversível do extravasamento (E)
pós-capilar de 89,0 ± 2,0 E/cm2  (grupo Ia) e 116,5 ± 4,8
E/cm2 (grupo Ib), p<0,001.
CONCLUSÃO: Esse estudo sugere que a utilização
crônica de solução de frutose a 10% ou 20% pode ser usada
para induzir experimentalmente um modelo estável de
hiperinsulinemia e hiperglicemia em hamsters. Este modelo
deverá facilitar o estudo de mecanismos básicos que
alteram a microcirculação, como demonstrado pelos
achados em isquemia/reperfusão já aos 2 meses.
UNITERMOS: Insulinemia, Glicemia, Solução de frutose,
Modelo experimental, Hamster.
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